Other risk factors that may increase vulnerability include: Long duration of diabetes (typically more than 10 years) Poor glycaemic control prior to starting GLP-1 therapy (HbA1c significantly above target) Rapid reduction in HbA1c (a drop of more than 2 percentage points [22 mmol/mol] within 36 months) Concurrent hypertension , especially if poorly controlled Diabetic kidney disease (nephropathy), which often correlates with retinopathy severity Previous history of retinal treatment (laser photocoagulation or intravitreal injections) People with type 2 diabetes but no retinopathy appear to have minimal risk of retinopathy progression based on current evidence
See our Tirzepatide pricing guide or Semaglutide pricing guide for current figures
It may take 13 days to produce effects and has relatively modest efficacy compared to other laxatives
When Dose Adjustments, Not Gaps, Are the Real Solution If you're experiencing side effects or cost concerns that make you consider skipping doses, your actual solution is talking with your PlexusDx care team about dose optimization or medication switching
Consistency matters more than duration
Documented symptomatic hypoglycaemia (according to ADA classification) [22] was also low (three subjects [five events] in the moderate renal impairment group and two subjects [two events] in the severe renal impairment group)